MP14-12 EXPLORING THE DUAL IMPACT TO TREATMENT OUTCOMES IN PATIENTS WITH SHORT TIME TO NADIR PSA UNDER ANDROGEN RECEPTOR PATHWAY INHIBITORS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER